ACAD vs CPRT · P/E 15, rev $576.0M vs P/E 19, rev $3.51B
ACADIA Pharmaceuticals Inc (ACAD) versus Copart Inc (CPRT) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Copart Inc (CPRT) is a specialty business services company listed on US.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Not investment advice. Open the ACAD and CPRT stock pages for the full models.
Not investment advice.